safinamide mesylate

Italy

Drugs containing this active substance

  • SAFINAMIDE AUROBINDO

    It is used for the treatment of Parkinson's disease in adults, particularly for patients in the intermediate to advanced stage who experience difficulty moving (transitions from 'ON' to 'OFF' states). It works by increasing dopamine levels in the brain.

    Form: tablets, film-coated

    Active substance Dosage
    safinamide mesylate -

    ATC: N04BD03

    Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.

  • This medicinal product is used for the treatment of Parkinson's disease in adults, particularly for patients in the intermediate to advanced stage who experience difficulty moving (transitions from 'ON' to 'OFF' states). It is added to levodopa therapy or used in combination with other drugs for Parkinson's disease.

    Form: tablets, film-coated

    Active substance Dosage
    safinamide mesylate -

    ATC: N04BD03

    Manufacturer: DOC GENERICI SRL

  • It is used for the treatment of Parkinson's disease in adults, particularly in patients with intermediate to advanced stage disease who experience difficulties in movement (fluctuations between 'ON' and 'OFF' states).

    Form: tablets, film-coated

    Active substance Dosage
    safinamide mesylate -

    ATC: N04BD03

    Manufacturer: EG S.P.A.

  • It is used for the treatment of Parkinson's disease in adults, particularly for patients in the intermediate to advanced stage who experience difficulty moving at certain times of the day (transitions from 'ON' to 'OFF' states). It is taken together with levodopa.

    Form: tablets, film-coated

    Active substance Dosage
    safinamide mesylate -

    ATC: N04BD03

    Manufacturer: TEVA ITALIA S.R.L.

  • It is used for the treatment of Parkinson's disease in adults, particularly for patients in the intermediate to advanced stage who experience difficulty moving at certain times of the day (transitions from 'ON' to 'OFF' states).

    Form: tablets, film-coated

    Active substance Dosage
    safinamide mesylate -

    ATC: N04BD03

    Manufacturer: ALFRED E. TIEFENBACHER GMBH & CO. KG

  • Xadago is used for the treatment of Parkinson's disease in adults, particularly for patients in the intermediate to advanced stage who experience sudden transitions from a state where they are able to move (ON state) to a state where they have difficulty moving (OFF state). The drug works by increasing dopamine levels in the brain.

    Form: tablets, film-coated

    Active substance Dosage
    safinamide mesylate -

    ATC: N04BD03

    Manufacturer: ZAMBON S.P.A.